Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Industries/Pharmaceutical

Pharmaceutical Medical Writing, Statistics and Regulatory Documentation

Pubrica supports pharmaceutical companies and clinical research teams with medical writing, statistical analysis and regulatory documentation for small-molecule drug development. Our services cover first-in-human studies, later-phase clinical development, regulatory submissions and post-approval activities. We develop clinical study protocols, statistical analysis plans, clinical study reports structured in accordance with ICH E3, and CTD Module 2 clinical and nonclinical overviews and summaries. We also support responses to health-authority queries and prepare manuscripts and other scientific publications. A designated project lead coordinates the work across documents, helping maintain consistent data interpretation, scientific messaging and alignment with the agreed submission or publication requirements.

What we writeICH-structured

Each document identifies the ICH guideline and version it follows.

On every project
  • One named lead throughout
  • Your SOPs and templates
  • Independent review, signed off
  • Mutual NDA on request
  • You remain the sponsor and author

Service Scope

Clinical and regulatory documents for small-molecule drug development.

We prepare clinical, statistical and regulatory documents for pharmaceutical sponsors. One named lead works across the programme, so the overview, study report and manuscript present the data consistently.

Written to

ICH E3, E6 and M4

Each deliverable states the guideline edition it follows.

Coordinated by

One named lead

One person across the protocol, analysis plan, study report and publication.

Reviewed by

A second qualified person

Independent review, quality control and reference verification, each signed off separately.

Our Services

Medical writing and regulatory documents we prepare.

Available as single documents or as a full programme. If a document depends on one we did not write, the scoping read reports on its condition first.

Documents and the guidelines they follow

Clinical study protocolWritten to ICH E6, with the statistical analysis plan developed in parallel
Statistical analysis planWritten before database lock, with reproducible code and traceable outputs
Clinical study reportStructured to ICH E3, including patient narratives and appendices
Investigator’s brochureUpdated as new safety data accumulate, rather than rewritten each year
Module 2.4 and 2.5Nonclinical and clinical overviews that interpret the data, not only summarise it
Module 2.6 and 2.7Written and tabulated summaries consistent with the underlying study reports
IND submissionsThe investigational new drug application, and the annual reports that follow it
NDA submissionsThe new drug application, with the integrated summaries of safety and efficacy
Health-authority responsesPrepared by the writer of the document under query
PSUR and DSURPeriodic safety reports prepared to the schedule set by your authorisation
Risk management planIncluding the pharmacovigilance and risk minimisation activities in the plan
Publications and congressPlanned around data readouts, following ICMJE authorship criteria and GPP

Product Types

Documentation by product type.

Document requirements differ by product. Orphan indications rely on data from small populations, over-the-counter products need labelling and safety documentation, and excipient and API suppliers need quality and compliance documentation.

Pharmaceutical segments and related sectors

Innovative pharmaceuticalsSmall molecules and advanced therapies that need a full clinical and regulatory document set
Specialty medicinesOrphan drugs, oncology and niche therapeutics with small populations and complex pathways
Over-the-counter productsLabelling, safety documentation and compliance files for consumer products
Excipients and APIsQuality documentation and regulatory filings for suppliers to other sponsors’ dossiers
Biologics and vaccinesComparability and immunogenicity documentation, covered on a separate page
GenericsBioequivalence reports and abridged dossiers, covered on a separate page
Devices and diagnosticsDocumentation under MDR and IVDR for notified body review, covered separately
NutraceuticalsRegulated under food law rather than medicines law, covered separately

Deliverables and Applications

Documents we prepare at each development stage.

Drug development runs from discovery to post-approval. You generate the science; we prepare the documents that regulators, journal editors and assessors review.

Discovery

Early scientific writing

Target rationale documents and early publications. We write up your research; we do not conduct it.

Preclinical

Nonclinical reports

Nonclinical study reports and Module 2.6 summaries, with animal work reported to ARRIVE 2.0.

Clinical

Protocol to study report

Protocols, analysis plans, ICH E3 study reports and publications planned around readouts.

Submission

Submission documents

Modules 2.4, 2.5 and 2.7, IND or NDA documents, and responses to health-authority queries.

Post-approval

Safety and lifecycle documents

PSUR and DSUR, the risk management plan, and supporting evidence for lifecycle claims.

Throughout

One named lead

Submission documents and earlier publications are kept consistent with each other.

All Services

Services available for pharmaceutical programmes.

Grouped by programme stage, so you can start with the stage you are at. Device and diagnostic services follow MDR and IVDR rather than ICH and are listed on the medical devices page instead.

Available individually or as a programme. When several run together, one named lead coordinates them so submission documents and publications stay consistent.

Who We Serve

Teams we work with in pharmaceutical companies.

The scoping read is tailored to the team that requests it.

Roles we support

Regulatory affairsCTD modules and submission documents prepared to your filing timeline
Medical writing leadsAdditional writing capacity that follows your templates
Clinical developmentProtocols and clinical study reports written to ICH guidelines
BiostatisticsStatistical analysis plans and outputs traceable to the code
PharmacovigilancePSURs, DSURs and other periodic safety reports to your reporting schedule
Medical affairsPublication plans and manuscripts aligned with your clinical data

Standards and Guidelines

Guidelines our documents follow.

Each deliverable names the guideline edition used and the date it was checked. When a guideline has changed recently, the deliverable states which version applies.

Guidelines relevant to small-molecule programmes

ICH E3Structure and content of clinical study reports
ICH E6 (R3)Good clinical practice
ICH E9Statistical principles, including the estimand framework
ICH M4The common technical document and its modules
FDA guidanceAgency-specific requirements in addition to ICH for US filings
EMA guidanceEU requirements, plus national requirements where applicable
CONSORT 2025Trial reporting, with the extension the design requires
ICMJE and GPP 2022Authorship, contributorship and good publication practice
COPEPublication ethics and the declarations that go with them
ISO 9001:2015The quality system the process itself runs under

Our Use of AI

Used for search and formatting. Not used to write your science.

This policy applies to every service and every deadline.

AI use policy

Used forLiterature search expansion, de-duplication, reference formatting and consistency checks
Not used forDrafting clinical argument, interpreting results, or generating any text a regulator will read as yours
DisclosedWhere a tool touched a deliverable, the handover says which tool and for what
Your dataNever used to train a model, and never sent to a service that would

How It Works

A five-step process, starting with a free scoping read.

We review your programme before providing a quote.

One

Scoping read

Two business days, at no cost. We set out the work required, the assigned team and the cost.

Two

Named team

You are told who is assigned and what they have worked on before anything starts.

Three

Outline signed off

Every section, what goes in it, which source it comes from — approved before drafting.

Four

Draft and review

Independent review, QC and reference verification, each signed off separately.

Five

Handover

The final document with its review reports, version-controlled and revised within the agreed scope.

After

Health-authority queries

The lead who wrote the document answers health-authority questions about it.

What you provide, what we provide

Send us what you have. We will tell you what is missing.

The scoping read includes an inventory of existing documents.

You send

The source

Protocol, data, previous documents, your templates and the submission date.

We send back

A written view

What exists, what is missing, what condition the existing documents are in.

Then

A scope and a figure

Quoted per programme, with the named team and the timeline, before you commit.

Our Experts

Our medical writers, statisticians and reviewers.

Writers hold a master’s degree or doctorate in life sciences, medicine or pharmacy and have at least five years of experience in the field. They are assigned by therapy area. Regulatory writers work to the guidance that governs their documents and keep up to date with it.

Specialists available for small-molecule programmes

Regulatory medical writersICH-structured documents, with the guidance edition tracked
StatisticiansAnalysis plans, estimands and reproducible outputs
Information specialistsReproducible searches for the literature-based components
Therapy-area leadsAssigned by indication, coordinating the programme across documents
Independent reviewersA second qualified person, who did not write the draft
Quality controlReference verification and consistency across the document set

Sample Work

Sample deliverables.

Published where the sponsor agreed, redacted where they asked.

Benefits

Benefits for pharmaceutical sponsors.

What clients told us they value.

Benefits of a single project lead

The documents agreeThe overview, study report and manuscript present the data consistently
Prompt query responsesBy the person who wrote the document being questioned
Guideline editions statedEach document records the guideline version it follows
Unlimited revisions within the agreed scopeWithin the agreed scope, without a per-round charge
Your templates and SOPsYour SOPs, your templates, your style guide
You are the sponsorNamed throughout; we do not offer ghost authorship

Packages

Quoted per programme, not per page.

Pricing is based on the work involved, not word count: a 4,000-word study report and a 4,000-word overview require different effort. The free scoping read produces a quote you can budget for.

First

Scoping read

Free, two business days. A written assessment of what the programme needs.

Then

A written scope

Documents, standards, named team and timeline, agreed before work starts.

Quoted

Per programme

One figure for the scope agreed, with revisions inside it rather than billed per round.

Quality Assurance

Revisions within the agreed scope.

If a deliverable does not meet the agreed scope, we rework it at no extra charge and repeat the independent review.

What the guarantee covers

Unlimited revisionsWithin the scope agreed, with no per-round charge
Independent re-reviewA second qualified person checks the rework, not the original author
The standard namedIf an incorrect guideline edition was applied, we correct it
Scope reviewIf the original scope was incorrect, we tell you rather than billing a change request

FAQs

Common questions from pharmaceutical sponsors.

Both, and you set the scope. We can draft modules from source data and your input, review and revise documents your team has written, or cover sections your internal writers do not have capacity for. Your qualified staff approve every document, and the sponsor signs off.

Modules 2.4 and 2.5 (the nonclinical and clinical overviews), the 2.6 and 2.7 summaries, and the Module 5 study reports that support them. Where a submission needs a literature-based component, we conduct the search and the synthesis.

Yes, and for sponsors it is the normal arrangement. We work inside your quality system, to your document templates and your style guide, with our ISO 9001:2015 certified process underneath rather than replacing it. Where you have no template we propose one and you approve it before drafting starts.

The named lead already knows the programme and wrote the document being queried, which supports a prompt response. Tell us the deadline at the scoping read. If it cannot be met to the required standard, we will say so at the start.

Independent review by a second qualified person, then quality control, then reference verification, each signed off separately. For statistical content the analysis is checked against the plan by somebody who did not run it. The reports come with the deliverable.

We quote per programme rather than per page, because word count does not reflect the work in a dossier module. The scoping read is free, takes two business days, and sets out the scope, named team, timeline and cost before you commit.

We do not operate your pharmacovigilance system. We write the risk management plan, PSUR and DSUR, but case processing and reporting to authorities stay within your PV system, under your qualified person. We do not conduct trials: we write the protocol, analysis plan and study report, and a contract research organisation runs the study. We do not audit or certify GMP or GCP compliance. We do not put our name on your science: you remain the sponsor and author throughout.

Related Services

Services often used alongside this work.

Small-molecule programmes often need several of these services.

Adjacent work

Regulatory writingThe full document set, including device and IVD files
BiostatisticsAnalysis plans, estimands and reproducible programming
Systematic reviewThe literature-based components of a submission
Market accessValue dossiers and the economic evidence payers assess
Therapy areasWhat the work looks like in your indication
Other sectorsBiologics, generics, devices and the rest

Discuss your pharmaceutical project requirements.

Tell us the indication and submission date. The scoping read is free, takes two business days, and gives you a written assessment of what the programme needs and who would lead it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.